Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: Exp Biol Med (Maywood). 2010 Oct;235(10):1168–1178. doi: 10.1258/ebm.2010.009347

Figure 1.

Figure 1

Activation of CRF1 signaling pathways and IBS-like manifestations, which can be blocked by CRF1 receptor antagonists. ANS, autonomic nervous system; ENS, enteric nervous system; IBS, irritable bowel syndrome (A color version of this figure is available in the online journal)